Compare INSM & LUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INSM | LUV |
|---|---|---|
| Founded | 1988 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 24.9B |
| IPO Year | 2000 | 1995 |
| Metric | INSM | LUV |
|---|---|---|
| Price | $130.21 | $47.02 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 24 | 18 |
| Target Price | ★ $201.17 | $45.37 |
| AVG Volume (30 Days) | 2.6M | ★ 5.3M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.93% |
| EPS Growth | N/A | ★ 3.95 |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | N/A |
| Revenue This Year | $182.31 | $16.57 |
| Revenue Next Year | $65.19 | $3.61 |
| P/E Ratio | ★ N/A | $53.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $90.39 | $28.98 |
| 52 Week High | $212.75 | $55.11 |
| Indicator | INSM | LUV |
|---|---|---|
| Relative Strength Index (RSI) | 74.77 | 53.85 |
| Support Level | $105.07 | $47.17 |
| Resistance Level | $166.34 | $50.13 |
| Average True Range (ATR) | 3.25 | 1.47 |
| MACD | 1.12 | 0.13 |
| Stochastic Oscillator | 96.88 | 71.72 |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayce and Brinsupri, are both part of the Respiratory therapeutic area. The firm's clinical-stage programs are TPIP, INS1148, brensocatib, and INS1201, focusing on different therapeutic areas. Additionally, Insmed's pre-clinical research programs encompass various technologies and modalities, including gene therapy, AI-driven protein engineering, protein manufacturing, RNA end-joining, and synthetic rescue. Geographically, the company generates maximum revenue from the United States from the sale of its commercial products.
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.